3-(4-isopropylphenyl)-5-methyl-4H-[1,2,4]triazole | 1094760-14-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-(4-isopropylphenyl)-5-methyl-4H-[1,2,4]triazole
• 英文别名: 5-methyl-3-(4-propan-2-ylphenyl)-1H-1,2,4-triazole
• CAS: 1094760-14-1
• 化学式: C₁₂H₁₅N₃
• 分子量: 201.271
• InChiKey: VDBVEMDJBJCPFK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• SMALL MOLECULE MODULATORS OF CELL ADHESION
  申请人：Gupta Mukur

  公开号：US20090291967A1

  公开（公告）日：2009-11-26

  Compounds, particularly compounds having activity as modulators of cadherin-mediated cell adhesion having the following structure: or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , A, X, Y, Z, m and n are as defined herein. Methods associated with preparation and use of the same, as well as pharmaceutical compositions containing the same, are also disclosed.

  化合物，特别是具有作为调节cadherin介导的细胞粘附活性的化合物，具有以下结构：或其药用盐、立体异构体或前药，其中R1、R2、R3、R4、R5、R6、A、X、Y、Z、m和n如本文所定义。与其制备和使用相关的方法，以及含有该化合物的药物组合物也被披露。
• NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
  申请人：Cooper Alan B.

  公开号：US20110189192A1

  公开（公告）日：2011-08-04

  Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.

  本发明公开了化学式1.0的ERK抑制剂，以及其药学上可接受的盐和溶剂化物。其中，Q代表四氢吡啶环。所有其他取代基的定义如本文所述。此外，本发明还公开了使用化合物1.0治疗癌症的方法。
• SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
  申请人：Andrews Steven W.

  公开号：US20120178715A1

  公开（公告）日：2012-07-12

  Compounds of Formula I: and salts thereof in which R 1 , R 2 , R 2a , R 3 , n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.

  式I的化合物及其盐，其中R1、R2、R2a、R3、n、X和环B具有规范中所给出的含义，是mTOR的抑制剂，可用于治疗对mTOR抑制敏感的疾病，如癌症。
• US8658651B2
  申请人：——

  公开号：US8658651B2

  公开（公告）日：2014-02-25
• US8716483B2
  申请人：——

  公开号：US8716483B2

  公开（公告）日：2014-05-06